Robert W. Duggan - 18 Dec 2024 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Dec 2024, 21:36:26 UTC
Prior SEC filing
17 Dec 2024
Next SEC filing
06 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact

Key filing fact

Robert W. Duggan filed Form 4 for PULSE BIOSCIENCES, INC. (PLSE) on 18 Dec 2024.

Key facts

  • This page summarizes Robert W. Duggan's Form 4 filing for PULSE BIOSCIENCES, INC. (PLSE).
  • 9 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 18 Dec 2024, 21:36.

Change

  • Previous filing in this sequence was filed on 17 Dec 2024.
  • Current net transaction value: +$58,367,716.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$57,066,064
Shares
+5,187,824
Change %
+12%
Price
$11.00
Shares after
47,516,541
Date
18 Dec 2024
Ownership
Direct
Footnotes
F1
PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$759,220
Shares
+69,020
Change %
+12%
Price
$11.00
Shares after
630,109
Date
18 Dec 2024
Ownership
Affiliated Company 1
Footnotes
F1, F2
PLSE transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$542,432
Shares
+49,312
Change %
+12%
Price
$11.00
Shares after
450,189
Date
18 Dec 2024
Ownership
Affiliated Company 2
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-2,593,912
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,593,912
Exercise price
$11.00
Footnotes
F4, F5
PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-2,593,912
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,593,912
Exercise price
$11.00
Footnotes
F4, F5
PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-34,510
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Affiliated Company 1
Underlying class
Common Stock
Underlying amount
34,510
Exercise price
$11.00
Footnotes
F2, F4, F5
PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-34,510
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Affiliated Company 1
Underlying class
Common Stock
Underlying amount
34,510
Exercise price
$11.00
Footnotes
F2, F4, F5
PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-24,656
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Affiliated Company 2
Underlying class
Common Stock
Underlying amount
24,656
Exercise price
$11.00
Footnotes
F3, F4, F5
PLSE transaction Derivative

Warrants (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares
-24,656
Change %
-100%
Price
Shares after
0
Date
18 Dec 2024
Ownership
Affiliated Company 2
Underlying class
Common Stock
Underlying amount
24,656
Exercise price
$11.00
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On December 18, 2024, the Reporting Person exercised warrants to purchase shares of the Issuer's common stock, at an exercise price of $11.00 per share.

Footnote F2

Shares and Warrants held by Genius 24C Inc., of which the Reporting Person is the sole shareholder.

Footnote F3

Shares and Warrants held by Blazon Corporation, of which the Reporting Person is the sole shareholder.

Footnote F4

The Reporting Person acquired the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.

Footnote F5

Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .